Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000179

Chairperson & CEO sold 7,777 shares at an average $599.64 ($4,663,396)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

25 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-04 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-04 Sale : show line 2 in the form 10b5-1 −39 $580.70 $22,647 333,904 I
2026-11-04 Sale : show line 3 in the form 10b5-1 −133 $582.18 $77,429 333,771 I
2026-11-04 Sale : show line 4 in the form 10b5-1 −188 $583.18 $109,639 333,583 I
2026-11-04 Sale : show line 5 in the form 10b5-1 −80 $584.14 $46,731 333,503 I
2026-11-04 Sale : show line 6 in the form 10b5-1 −280 $585.60 $163,969 333,223 I
2026-11-04 Sale : show line 7 in the form 10b5-1 −280 $586.92 $164,337 332,943 I
2026-11-04 Sale : show line 8 in the form 10b5-1 −400 $588.21 $235,284 332,543 I
Open-market sales · 7,777 sh · avg $599.64 · $4,663,396

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-04 Exercise or conversion : show line 26 in the form 10b5-1 Stock Option −9,500 90,910 I
Loading xslF345X06/primarydocument.xml…